Maria Asuncion Mejias

Title: Maria Asuncion Mejias: Innovator in Respiratory Syncytial Virus Research

Introduction

Maria Asuncion Mejias is a prominent inventor based in Columbus, OH (US). She has made significant contributions to the field of virology, particularly in the study of respiratory syncytial virus (RSV). Her innovative work focuses on enhancing the immune response against RSV, which is crucial for developing effective vaccines.

Latest Patents

Maria holds a patent for "Respiratory syncytial virus having altered NS1 protein function and related materials and methods." This patent describes compositions, methods, and uses for RSV and immunogenic compositions. The invention includes RSV with a mutated NS1 protein that uncouples its replication and type I interferon antagonist functions. This uncoupling can lead to virions that induce a strong, long-lasting innate immune response while retaining their ability to replicate in vitro. The patent also outlines methods for amplifying RSV in host cells, resulting in a mutated NS1 protein that enhances immune response against RSV infection.

Career Highlights

Throughout her career, Maria has worked at notable institutions, including the Research Institute at Nationwide Children's Hospital and the University of South Florida. Her research has significantly advanced the understanding of RSV and its interactions with the immune system.

Collaborations

Maria has collaborated with esteemed colleagues such as Mark Edward Peeples and Michael Nan-hao Teng. These collaborations have further enriched her research and contributed to the development of innovative solutions for RSV.

Conclusion

Maria Asuncion Mejias is a trailblazer in the field of respiratory syncytial virus research. Her patented innovations and collaborative efforts are paving the way for improved vaccines and therapeutic strategies against RSV.